一个单核酸多态性影响全二醇的药理动力学和血清尿酸水平的系统审查
Farah Aida A Zairol Azwan1, Yi Ying Teo1, Nor Asyikin Mohd Tahir1
1Centre for Quality Management of Medicines, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Jalan Raja Muda Abdul Aziz, 50300, Kuala Lumpur, Malaysia.
Pharmacogenomics
|September 30, 2024
概括
单核酸多态 (SNPs) 影响身体如何处理全氨醇,影响尿酸控制. 已识别的SNP显示了多种效应,突出了研究中的不一致性.
科学领域:
- 药物基因组学 药物基因组学
- 临床药理学 临床药理学
背景情况:
- 艾洛普醇是治疗高尿血和痛风的关键药物.
- 了解对阿洛普林醇药理动学的遗传影响对于个性化治疗至关重要.
研究的目的:
- 综合单核酸多态 (SNP) 对全氨醇药理学的影响.
- 评估这些遗传变异在控制尿酸水平方面的作用.
主要方法:
- 在PubMed,Web of Science和Scopus数据库中进行了系统的文献审查.
- 包括17项研究,研究了SNP与阿洛普林醇及其活性代谢物氧普林醇的药理动力学之间的关联.
主要成果:
- 十一种SNP与阿洛普林醇和氧普林醇的药理动力学有显著的关联.
- 在ABCG2,SLC2A9,SLC17A1,SLC22A12,SLC22A13,PDZK1和AOX1基因中的SNP与氨醇清除和代谢有关.
- GREM2基因变异影响了尿酸控制,尽管机制尚不清楚.
结论:
- 遗传变异,特别是SNP,显著影响阿洛普林醇的药理动力学和疗效.
- 已识别的SNP对尿酸控制具有复杂且有时相互矛盾的作用.
- 需要进一步的研究来阐明这些遗传关联的确切机制和临床影响.
相关概念视频
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
102
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
102
Phase II Reactions: Glucuronidation
312
Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid...
312
Nonlinear Pharmacokinetics: Overview
302
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
302
Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels
189
Renal clearance of a drug is influenced by various factors, including its physicochemical properties and plasma levels. These factors play a significant role in determining how efficiently the kidneys eliminate a drug.
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
189
Nonlinear Pharmacokinetics: Role of Transporters
40
A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
Polymorphisms occurring in drug transporters can alter...
40
Renal Failure: Dose Adjustments
68
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
68


